Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The website has added new dates including 2024-12-11 and 2034-11-20, and updated to Revision v2.13.3, while removing several dates and reverting to an earlier version, v2.13.2.
    Difference
    0.3%
    Check dated 2024-12-17T13:45:02.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    1%
    Check dated 2024-12-10T07:31:49.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    New entries were added on November 22 and November 26, 2024, while entries from November 14 and November 18, 2024, were removed.
    Difference
    0.1%
    Check dated 2024-12-02T22:29:57.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The Institute of Science Tokyo Hospital has been added as a new site, while numerous study coordinator contact details have been removed, indicating a significant update in site management and contact information.
    Difference
    14%
    Check dated 2024-11-25T13:33:03.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The website has been updated from version v2.11.2 to v2.12.1.
    Difference
    0.1%
    Check dated 2024-11-04T09:32:45.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    New study numbers and definitions related to carcinoma in situ (CIS) response metrics have been added, while similar entries from previous dates have been removed.
    Difference
    0.6%
    Check dated 2024-10-17T19:59:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.